IDEXX Laboratories faces a notable decline amid market shifts.
IDEXX Laboratories Inc. (NASDAQ:IDXX) experienced a significant drop of 1.58% in its stock price, closing at CA$518.75. This decline comes as the company prepares for its upcoming third-quarter financial results, scheduled for November 2, 2026.
Advertisement
IDEXX Laboratories Inc
IDXX.US
IDXX.US
IDEXX Laboratories Inc
WealthAwesomeMarket cap
$40.89B
P/E
36.4x
52W high
$769.98
52W low
$500.61
1W change
-0.38%
Beta
1.54
Analyst Price Targets
Based on 13 analysts covering IDXX · as of Oct 5, 2026
Wall Street analysts forecast IDXX stock price to rise 33.1% over the next 12 months.
Consensus
Buy3.85 / 5.00
Avg. Target
C$701.33
+33.1% Upside
Current Price
C$527.07
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IDXX's historical volatility
30-Day Vol
21.5%
Annualized
90-Day Vol
29.1%
Annualized
Trend (90d)
-28.1%
Annualized drift
90d Mean
C$476.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$509.72 | C$473.28 – C$548.96 |
| 60 trading days | C$492.93 | C$443.85 – C$547.45 |
| 90 trading days | C$476.70 | C$419.24 – C$542.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may want to exercise caution as IDEXX's recent performance indicates potential volatility ahead of its earnings report.
IDEXX's stock down 1.58% today
The market cap of IDEXX stands at approximately CA$41.5 billion, reflecting its significant presence in the veterinary diagnostics sector.
Bull case
IDEXX's recent acquisitions, like CoVetAI, position the company well in the expanding veterinary technology market, which is expected to grow significantly over the next decade.
Bear case
The recent drop in stock price raises concerns among investors about IDEXX's ability to sustain growth amid rising competition and market pressures.
Advertisement
Market Reaction and Future Outlook
The recent drop in IDEXX's stock price reflects broader market concerns as investors await the company's third-quarter earnings report. With a P/E ratio of 37.04, the stock remains relatively expensive compared to its peers, which could lead to further scrutiny from analysts and investors alike.
Acquisition Strategy Under Pressure
IDEXX's recent acquisition of CoVetAI, while a smart move, may not be enough to ease investor worries about future growth. The integration of AI technology in veterinary medicine shows promise, but the market's reaction suggests that investors are cautious about potential challenges in execution and competition.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
